# FDA recall D-0376-2022

> **VistaPharm, Inc.** · Class II · drug recall initiated 2022-01-07.

## Product

Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only,  Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04

## Reason for recall

Failed Stability Specifications

## Distribution

Nationwide within the United States including Puerto Rico

## Key facts

- **Recall number:** D-0376-2022
- **Recalling firm:** VistaPharm, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-01-07
- **Report date:** 2022-01-26
- **Termination date:** 2024-12-13

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Largo, FL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0376-2022

## Citation

> AI Analytics. FDA recall D-0376-2022. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0376-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*